yeh they reaffirmed guidance so at these prices its quite reasonable. I wouldnt worry about it too much. Probaly a good time to be buying more
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025